Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Diabetes Tools to acquire DiabetesGuru child app“The deal with DiabetesGuru adds a new dimension to our digital health product portfolio,” said Diabetes Tools’ Chief Executive Officer Anders Weilandt. “Whereas TriabetesGo, our app for keeping insulin-dependent children connected with their families and doctors, is exclusively available from treatment clinics using the TriabetesClinic service, DiabetesGuru is a standalone app and can therefore be used by children and families when a TriabetesClinic affiliation is not offered in their local area.” “I created DiabetesGuru out of necessity to help my young son with his diabetes,” said DiabetesGuru’ According to today’s deal, Diabetes Tools will own the rights to the DiabetesGuru app in addition to other marketing and brand assets. The software assets will be formally transferred during the next few months so DiabetesGuru can become part of the Diabetes Tools quality management framework and product portfolio. Then, the company expects to offer DiabetesGuru as a free-of-charge, standalone app available from online app stores as it is today. Triabetes is a trademark of Diabetes Tools Sweden AB. About Diabetes Tools Diabetes Tools is a Swedish medical technology company that simplifies daily life for everyone involved in diabetes care. The TriabetesClinic software service securely combines apps (for smartphones and tablets), online accounts and web interfaces to change diabetes healthcare for the better. Diabetes Tools was named “MedTech Company of the Year 2014” by the Swedish Medtech Association. The company holds an ISO 13485 certificate, a compliance standard for creating medical devices and related services, and sells CE-marked medical software products in the European Union. Diabetes Tools is privately held and located in Stockholm, Sweden. More information at http://www.diabetestools.se. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|